VWM
AVXL icon

Vermillion Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Vermillion Wealth Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.18K Hold
2,000
– – ﹤0.01% 1354
2026
Q1 		$6.14K Sell
2,000
-1,177
-37% -$5.1K ﹤0.01% 459
2025
Q4 		$11.3K Hold
3,177
– – ﹤0.01% 364
2025
Q3 		$28.3K Hold
3,177
– – 0.01% 753
2025
Q2 		$29.3K Hold
3,177
– – 0.01% 223
2025
Q1 		$27.3K Hold
3,177
– – 0.01% 640
2024
Q4 		$34.1K Buy
+3,177
New +$24.4K 0.02% 212

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vermillion Wealth Management's AVXL Position: Q2 2026 in Review

Vermillion Wealth Management held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 2,000 shares worth $5.18K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Vermillion Wealth Management first reported a position in AVXL in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.1K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Vermillion Wealth Management held 2,000 shares of Anavex Life Sciences worth $5.18K as of Q2 2026.
  • Vermillion Wealth Management left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1354 holding.
  • Vermillion Wealth Management first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Anavex Life Sciences position peaked at $34.1K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.